Physiotherapy Programme, Department of Therapy and Rehabilitation, IMU Vocational School, Istanbul Medipol University, Istanbul, Turkey.
Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Free Radic Res. 2024 Mar-Apr;58(4):249-260. doi: 10.1080/10715762.2024.2339892. Epub 2024 Apr 16.
This study aimed to examine the effects of low-level laser therapy (LLLT) combined with levothyroxine replacement therapy on thyroid function, oxidative stress (OS), and quality of life in patients with Hashimoto's thyroiditis (HT). Forty-six patients diagnosed with HT were randomized to receive active LLLT ( = 23) and sham LLLT ( = 23) twice a week for three weeks. Clinical and laboratory evaluations of the participants were performed before treatment and three months after treatment. Biochemical parameters were taken from the patient file requested by the physician as a routine examination. Malondialdehyde and nitricoxide indicating oxidant stress and superoxide dismutase, catalase, and glutathione, which indicate antioxidant capacity, were used in OS evaluation. The Oxidative Stress Index was calculated by measuring the Total Antioxidant Status and the Total Oxidant Status. At the end of our study, a significant improvement in oxidant and antioxidant biomarker levels showing OS and quality of life was observed in the treatment groups ( < 0.05). There was no change in thyroid function and autoimmunity at the end of the treatment between the two groups ( > 0.05). Improvements in glutathione levels and quality of life were significantly higher in the active treatment group than in the sham-controlled group. LLLT was found to be more effective on OS and quality of life in patients with HT than in patients in the sham-controlled group. It was concluded that LLLT is a safe and effective method that can be used in the treatment of patients with HT.
本研究旨在探讨低水平激光疗法(LLLT)联合左甲状腺素替代疗法对桥本甲状腺炎(HT)患者甲状腺功能、氧化应激(OS)和生活质量的影响。46 名确诊为 HT 的患者被随机分为接受主动 LLLT(n=23)和假 LLLT(n=23)治疗,每周两次,共治疗 3 周。在治疗前和治疗后 3 个月对参与者进行临床和实验室评估。生化参数是从医生要求的患者病历中获取的常规检查。使用丙二醛和一氧化氮来评估氧化应激,使用超氧化物歧化酶、过氧化氢酶和谷胱甘肽来评估抗氧化能力。通过测量总抗氧化状态和总氧化状态来计算氧化应激指数。在我们的研究结束时,治疗组的氧化和抗氧化生物标志物水平显著改善,表明 OS 和生活质量得到改善(<0.05)。治疗结束时,两组之间的甲状腺功能和自身免疫均无变化(>0.05)。与假对照组相比,主动治疗组的谷胱甘肽水平和生活质量改善更为显著。与假对照组相比,LLLT 对 HT 患者的 OS 和生活质量更有效。结论是,LLLT 是一种安全有效的治疗 HT 患者的方法。